Developing strategies to improve the quality of life of patients with gluten intolerance in patients with and without coeliac disease

European Journal of Internal Medicine

Volumn 23, Issue 1, 2012, Pages 6-8

  Bernardo, D ^a   Pena A S ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTEN; INTERLEUKIN 15 RECEPTOR;

CELIAC DISEASE; CELL HYPERPLASIA; CRYPT CELL; CYTOKINE PRODUCTION; GLUTEN FREE DIET; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INTESTINE VILLUS ATROPHY; LYMPHOCYTIC INFILTRATION; QUALITY OF LIFE; REVIEW;

EID: 83555174351     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.09.016     Document Type: Editorial

References (47)

1. S. Riestra, E. Fernandez, L. Rodrigo, S. Garcia, and G. Ocio Prevalence of coeliac disease in the general population of northern Spain. Strategies of serologic screening Scand J Gastroenterol 35 2000 398 402 (Pubitemid 30304423)
2. M. Schapira, J.M. Maisin, J.M. Ghilain, S. De Maeght, P. Deltenre, and J. Henrion Epidemiology of coeliac disease Acta Gastroenterol Belg 66 2003 234 236 (Pubitemid 37295884)
3. J. West, R.F. Logan, P.G. Hill, A. Lloyd, S. Lewis, and R. Hubbard Seroprevalence, correlates, and characteristics of undetected coeliac disease in England Gut 52 2003 960 965 (Pubitemid 36765286)
4. C. Catassi, I.M. Ratsch, E. Fabiani, M. Rossini, F. Bordicchia, and F. Candela Coeliac disease in the year 2000: exploring the iceberg Lancet 343 1994 200 203
5. L.M. Sollid Coeliac disease: dissecting a complex inflammatory disorder Nat Rev Immunol 2 2002 647 655 (Pubitemid 37328722)
6. V. Abadie, L.M. Sollid, L.B. Barreiro, and B. Jabri Integration of genetic and immunological insights into a model of celiac disease pathogenesis Annu Rev Immunol 29 2011 493 525
7. P.H. Green, and C. Cellier Celiac disease N Engl J Med 357 2007 1731 1743
8. S.H. Barton, and J.A. Murray Celiac disease and autoimmunity in the gut and elsewhere Gastroenterol Clin North Am 37 2008 411 428 vii (Pubitemid 351680533)
9. M. Hadjivassiliou, D.S. Sanders, R.A. Grunewald, N. Woodroofe, S. Boscolo, and D. Aeschlimann Gluten sensitivity: from gut to brain Lancet Neurol 9 2010 318 330
10. A. Vincent, and P.B. Crino Systemic and neurologic autoimmune disorders associated with seizures or epilepsy Epilepsia 52 2011 12 17
11. C. Cellier, N. Patey, L. Mauvieux, B. Jabri, E. Delabesse, and J.P. Cervoni Abnormal intestinal intraepithelial lymphocytes in refractory sprue Gastroenterology 114 1998 471 481 (Pubitemid 28141192)
12. M. Hadithi, and A.S. Peña Current methods to diagnose the unresponsive and complicated forms of coeliac disease Eur J Intern Med 21 2010 247 253
13. J.J. Mention, M. Ben Ahmed, B. Begue, U. Barbe, V. Verkarre, and V. Asnafi Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease Gastroenterology 125 2003 730 745 (Pubitemid 37070691)
14. A. Rubio-Tapia, and J.A. Murray Classification and management of refractory coeliac disease Gut 59 2010 547 557
15. B. Roshan, D.A. Leffler, S. Jamma, M. Dennis, S. Sheth, and K. Falchuk The incidence and clinical spectrum of refractory celiac disease in a North American referral center Am J Gastroenterol 106 2011 923 928
16. A. Lanzini, F. Lanzarotto, V. Villanacci, A. Mora, S. Bertolazzi, and D. Turini Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet Aliment Pharmacol Ther 29 2009 1299 1308
17. A. Camarca, R.P. Anderson, G. Mamone, O. Fierro, A. Facchiano, and S. Costantini Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease J Immunol 182 2009 4158 4166
18. I. Comino, A. Real, L. de Lorenzo, H. Cornell, M.A. Lopez-Casado, and F. Barro Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease Gut 60 2011 915 922
19. P. Brandtzaeg The changing immunological paradigm in coeliac disease Immunol Lett 105 2006 127 139 (Pubitemid 43816092)
20. B. Jabri, and L.M. Sollid Mechanisms of disease: immunopathogenesis of celiac disease Nat Clin Pract Gastroenterol Hepatol 3 2006 516 525 (Pubitemid 44322763)
21. M. Londei, C. Ciacci, I. Ricciardelli, L. Vacca, S. Quaratino, and L. Maiuri Gliadin as a stimulator of innate responses in celiac disease Mol Immunol 42 2005 913 918 (Pubitemid 40489015)
22. L. Maiuri, C. Ciacci, I. Ricciardelli, L. Vacca, V. Raia, and S. Auricchio Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease Lancet 362 2003 30 37 (Pubitemid 36835817)
23. A. Di Sabatino, R. Ciccocioppo, F. Cupelli, B. Cinque, D. Millimaggi, and M.M. Clarkson Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease Gut 55 2006 469 477
24. T. Matysiak-Budnik, C. Candalh, C. Dugave, A. Namane, C. Cellier, and N. Cerf-Bensussan Alterations of the intestinal transport and processing of gliadin peptides in celiac disease Gastroenterology 125 2003 696 707 (Pubitemid 37070688)
25. M.G. Clemente, S. De Virgiliis, J.S. Kang, R. Macatagney, M.P. Musu, and M.R. Di Pierro Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function Gut 52 2003 218 223 (Pubitemid 36115062)
26. L. Maiuri, C. Ciacci, S. Auricchio, V. Brown, S. Quaratino, and M. Londei Interleukin 15 mediates epithelial changes in celiac disease Gastroenterology 119 2000 996 1006
27. B. Meresse, Z. Chen, C. Ciszewski, M. Tretiakova, G. Bhagat, and T.N. Krausz Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease Immunity 21 2004 357 366 (Pubitemid 39208337)
28. S. Hue, J.J. Mention, R.C. Monteiro, S. Zhang, C. Cellier, and J. Schmitz A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease Immunity 21 2004 367 377 (Pubitemid 39208338)
29. E.C. Ebert IL-15 converts human intestinal intraepithelial lymphocytes to CD94 producers of IFN-gamma and IL-10, the latter promoting Fas ligand-mediated cytotoxicity Immunology 115 2005 118 126 (Pubitemid 40593298)
30. D. Bernardo, J.A. Garrote, Y. Allegretti, A. Leon, E. Gomez, and J.F. Bermejo-Martin Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients Clin Exp Immunol 154 2008 64 73
31. M. Raki, S. Tollefsen, O. Molberg, K.E. Lundin, L.M. Sollid, and F.L. Jahnsen A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells Gastroenterology 131 2006 428 438 (Pubitemid 44142462)
32. S.W. Qiao, E. Bergseng, O. Molberg, J. Xia, B. Fleckenstein, and C. Khosla Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion J Immunol 173 2004 1757 1762 (Pubitemid 38971607)
33. S. Tollefsen, H. Arentz-Hansen, B. Fleckenstein, O. Molberg, M. Raki, and W.W. Kwok HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease J Clin Invest 116 2006 2226 2236 (Pubitemid 44162332)
34. E.M. Nilsen, K.E. Lundin, P. Krajci, H. Scott, L.M. Sollid, and P. Brandtzaeg Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma Gut 37 1995 766 776
35. G.R. Sander, A.G. Cummins, T. Henshall, and B.C. Powell Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins FEBS Lett 579 2005 4851 4855 (Pubitemid 41218674)
36. S. Drago, R. El Asmar, M. Di Pierro, M. Grazia Clemente, A. Tripathi, and A. Sapone Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines Scand J Gastroenterol 41 2006 408 419 (Pubitemid 43675406)
37. E. Dolfini, L. Elli, L. Roncoroni, B. Costa, M.P. Colleoni, and V. Lorusso Damaging effects of gliadin on three-dimensional cell culture model World J Gastroenterol 11 2005 5973 5977 (Pubitemid 41749210)
38. D. Bernardo, J.A. Garrote, L. Fernandez-Salazar, S. Riestra, and E. Arranz Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides Gut 56 2007 889 890 (Pubitemid 46854215)
39. L. Jelinkova, L. Tuckova, J. Cinova, Z. Flegelova, and H. Tlaskalova-Hogenova Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB FEBS Lett 571 2004 81 85 (Pubitemid 38992927)
40. J. Cinova, L. Palova-Jelinkova, L.E. Smythies, M. Cerna, B. Pecharova, and M. Dvorak Gliadin peptides activate blood monocytes from patients with celiac disease J Clin Immunol 27 2007 201 209 (Pubitemid 46348718)
41. E. Dolfini, L. Elli, T. Dasdia, B. Bufardeci, M.P. Colleoni, and B. Costa In vitro cytotoxic effect of bread wheat gliadin on the LoVo human adenocarcinoma cell line Toxicol In Vitro 16 2002 331 337 (Pubitemid 34756424)
42. C. Giovannini, E. Mancini, and M. De Vincenzi Inhibition of the cellular metabolism of Caco-2 cells by prolamin peptides from cereals toxic for coeliacs Toxicol In Vitro 10 1996 533 538 (Pubitemid 26426975)
43. C. Giovannini, P. Matarrese, B. Scazzocchio, R. Vari, M. D'Archivio, and E. Straface Wheat gliadin induces apoptosis of intestinal cells via an autocrine mechanism involving Fas-Fas ligand pathway FEBS Lett 540 2003 117 124 (Pubitemid 36398043)
44. C. Giovannini, M. Sanchez, E. Straface, B. Scazzocchio, M. Silano, and M. De Vincenzi Induction of apoptosis in caco-2 cells by wheat gliadin peptides Toxicology 145 2000 Apr 7 63 71 (Pubitemid 30190267)
45. J.R. Biesiekierski, E.D. Newnham, P.M. Irving, J.S. Barrett, M. Haines, and J.D. Doecke Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial Am J Gastroenterol 106 2011 508 514
46. J.R. Biesiekierski, O. Rosella, R. Rose, K. Liels, J.S. Barrett, and S.J. Shepherd Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals J Hum Nutr Diet 24 2011 154 176
47. L.M. Sollid, and C. Khosla Novel therapies for coeliac disease J Intern Med 269 2011 604 613